How would you approach patient selection for DBS after chronic post-stroke for motor rehabilitation in light of the recent phase 1 clinical trial?
1 Answer
Mednet MemberInvited Expert
Neurosurgery · University of Arizona
Answered on
These two neurostimulation modalities occupy fundamentally different positions in the treatment landscape. VNS paired with rehabilitation (Vivistim) is the only FDA-approved neuromodulation therapy for chronic post-stroke upper-extremity motor rehabilitation, supported by a pivotal phase III RCT and...
Join for free or sign in to see the full answer